StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd

<< Previous

Bullboard Posts

Next >>

Post by kodiakupon Jan 29, 2021 7:30pm

205 Views

Post# 32426642

House Positions for C:SZLS.WT Today ....

House Positions for C:SZLS.WT from 20210129 to 20210129

House	Bought	$Val	Ave	Sold	$Val	Ave	Net	$Net
7 TD Sec	164,000	11,620	0.071	897	67	0.075	163,103	-11,553
124 Questrade	160,000	12,000	0.075	0			160,000	-12,000
85 Scotia	57,800	4,046	0.07	0			57,800	-4,046
2 RBC	110,000	7,750	0.07	97,000	7,275	0.075	13,000	-475
9 BMO Nesbitt	0			10,000	700	0.07	-10,000	700
79 CIBC	70,897	5,147	0.073	101,000	7,240	0.072	-30,103	2,093
19 Desjardins	0			75,000	5,250	0.07	-75,000	5,250
1 Anonymous	0			103,000	7,725	0.075	-103,000	7,725
33 Canaccord	1,000	70	0.07	176,800	12,376	0.07	-175,800	12,306
TOTAL	563,697	40,633	0.072	563,697	40,633	0.072	0	0